Company AccuStem Sciences, Inc.

Equities

ACUT

US00444A1016

Medical Equipment, Supplies & Distribution

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets Other stock markets 20:27:01 22/05/2024 BST			5-day change	1st Jan Change
0.35 ^USD	+11.09%		+26.35%	-44.06%

05-20	AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-22	AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

AccuStem Sciences, Inc. is a clinical-stage diagnostics company. The Company is focused on developing and commercializing a suite of genomic tests that support decision-making along the entire continuum of oncology care. The Company's product candidate is StemPrintER, a 20-gene prognostic assay intended to predict the risk of distant recurrence (DR) in luminal (ER+/HER2-negative) breast cancer patients. In addition, the Company is focused on offering ancillary commodity testing (hereditary genetic testing, somatic mutation testing) that augments its assays and provides additional information to patients and physicians throughout the patient care continuum. The Company also holds licensing rights for the MicroRNA Signature Classifier (MSC) test, which is designed to help determine whether lung nodules identified by low-dose computed tomography (LDCT) screening are benign or malignant. The Company's wholly owned subsidiary is StemPrintER Sciences Limited.

Number of employees: 3

Managers	Title	Age	Since
Wendy Blosser CEO	Chief Executive Officer	57	03/03/22
Keeren Shah DFI	Director of Finance/CFO	47	31/07/21
Joe Flanagan PRN	Corporate Officer/Principal	49	03/03/22

Members of the board	Title	Age	Since
John Brancaccio BRD	Director/Board Member	76	28/02/21
Willy Simon BRD	Director/Board Member	72	28/02/21
Gabriele Cerrone FOU	Founder	52	04/06/20
Sean McDonald BRD	Director/Board Member	63	13/11/22
Wendy Blosser CEO	Chief Executive Officer	57	03/03/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	11,346,535	6,165,303 ( 54.34 %)	0	54.34 %

Name	Equities	%	Valuation
Gabriele Cerrone 33.79 %	3,831,223	33.79 %	1 M $
TIZIANA LIFE SCIENCES LTD 11.80 %	1,337,970	11.80 %	445 544 $
Willy Simon 0.0863 %	9,789	0.0863 %	3 260 $
Wendy Blosser 0.0176 %	2,000	0.0176 %	666 $
Keeren Shah 0.002205 %	250	0.002205 %	83 $
John Brancaccio 0.000000 %	0	0.000000 %	- $
Joe Flanagan 0.000000 %	0	0.000000 %	- $

AccuStem Sciences, Inc.

5 Penn Plaza 19th Floor

10001, New York

http://accustem.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ACCUSTEM SCIENCES, INC.	-44.06%	3.97M
ABBOTT LABORATORIES	-4.77%	182B
MEDTRONIC PLC	+4.10%	114B
BECTON, DICKINSON AND COMPANY	-3.85%	67.76B
DEXCOM, INC.	+5.19%	51.91B
CENCORA, INC.	+5.54%	43.23B
HOYA CORPORATION	+6.07%	41.07B
METTLER-TOLEDO INTERNATIONAL, INC.	+23.81%	32.07B
TERUMO CORPORATION	+15.86%	25B
WEST PHARMACEUTICAL SERVICES, INC.	-5.06%	24.35B

Other Medical Equipment, Supplies & Distribution